Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Liabilities and Shareholders Equity (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $74.9 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 23.75% to $74.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $320.3 million through Dec 2025, down 28.64% year-over-year, with the annual reading at $74.9 million for FY2025, 23.75% down from the prior year.
  • Liabilities and Shareholders Equity hit $74.9 million in Q4 2025 for Rapid Micro Biosystems, down from $84.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $254.4 million in Q3 2021 to a low of $74.9 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $150.6 million across 5 years, with a median of $143.5 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 244.54% in 2021 and later crashed 35.44% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $241.2 million in 2021, then fell by 20.95% to $190.6 million in 2022, then fell by 24.76% to $143.5 million in 2023, then plummeted by 31.57% to $98.2 million in 2024, then dropped by 23.75% to $74.9 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for RPID at $74.9 million in Q4 2025, $84.4 million in Q3 2025, and $75.6 million in Q2 2025.